반응식
[Cl:1][C:2]1[C:10]2[N:9]=[C:8]([CH2:11][CH3:12])[NH:7][C:6]=2[CH:5]=[CH:4][C:3]=1[C:13]#[N:14].[F:15][C:16]([F:35])([F:34])[C:17]1[CH:18]=[C:19]([C:27]2[O:31][N:30]=[C:29]([CH2:32]Cl)[N:28]=2)[CH:20]=[C:21]([C:23]([F:26])([F:25])[F:24])[CH:22]=1>>[F:35][C:16]([F:15])([F:34])[C:17]1[CH:18]=[C:19]([C:27]2[O:31][N:30]=[C:29]([CH2:32][N:7]3[C:6]4[CH:5]=[CH:4][C:3]([C:13]#[N:14])=[C:2]([Cl:1])[C:10]=4[N:9]=[C:8]3[CH2:11][CH3:12])[N:28]=2)[CH:20]=[C:21]([C:23]([F:25])([F:24])[F:26])[CH:22]=1참가 물질
3
실험 절차
Synthesized as described in Example 197B from 4-chloro-2-ethyl-1H-benzimidazole-5-carbonitrile and 5-[3,5-bis(trifluoromethyl)phenyl]-3-(chloromethyl)-1,2,4-oxadiazole: MS (ESI) m/z 500 (M+1).
후처리
- customSynthesized
출처 및 근거
- ORD 기록
- ord-a7061e28db3b459a8f01e7a73e76ca6f
- 출처 데이터셋
- uspto-grants-2011_09
- 특허 번호
- US08026262B2
연결된 노트
불러오는 중…